Co-Authors
This is a "connection" page, showing publications co-authored by Alfredo Papa and Antonio Gasbarrini.
Connection Strength
1.762
-
How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists. Vaccines (Basel). 2021 Mar 12; 9(3).
Score: 0.233
-
Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients. Gastroenterology. 2021 07; 161(1):368-369.
Score: 0.231
-
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase. Therap Adv Gastroenterol. 2020; 13:1756284820968747.
Score: 0.227
-
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020 10; 115(10):1722-1724.
Score: 0.226
-
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-a on the Liver. Int J Mol Sci. 2018 Jul 27; 19(8).
Score: 0.195
-
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
Score: 0.185
-
Can We Predict the Efficacy of Anti-TNF-a Agents? Int J Mol Sci. 2017 Sep 14; 18(9).
Score: 0.183
-
Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005 Dec 14; 11(46):7227-36.
Score: 0.081
-
Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005 Apr; 100(4):886-95.
Score: 0.077
-
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
Score: 0.056
-
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
Score: 0.055
-
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Aliment Pharmacol Ther. 1998 Jun; 12(6):539-43.
Score: 0.012